AVD

Business Context and Reporting Period

Company: American Vanguard Corp (AMVAC)

Filing Type: Form 10-Q (Quarterly Report)

Reporting Period: Three months ended March 31, 2004

Business Overview: The Company operates in a single reportable segment, primarily manufacturing and selling crop protection products (insecticides, herbicides, fungicides) and non-crop products. The Company is headquartered in Newport Beach, California.

Key Financial Metrics

Note: Debt figures derived from Balance Sheet: Current installments of long-term debt ($4,406) + Other long-term debt ($8,554) + Note payable to bank ($30,000) = $42,960.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 25% to $34.2 million, driven primarily by a 32% increase in crop product sales ($31.0 million vs. $23.6 million). Non-crop sales declined 15%.
• Profitability: Net income increased 80% to $2.2 million. Gross profit margins improved from 42% to 44% due to favorable product mix changes.
• Operating Expenses: Increased 21% to $11.3 million. Selling expenses rose $1.2 million due to higher sales volume and variable costs. General and administrative expenses increased $0.8 million due to amortization of intangible assets and professional fees. Research and development costs decreased $0.5 million.
• Cash Flow: Operating cash flow was negative $10.0 million, compared to negative $7.9 million in the prior year. This was primarily due to a $19.4 million increase in receivables and a $4.7 million increase in inventories to meet future sales expectations.
• Financing: The Company increased borrowings under its revolving line of credit by $15.8 million to fund working capital needs. Total debt increased significantly due to the drawdown on the credit facility.

Guidance, Outlook, and Risks

• Stock Split and Dividend: On March 16, 2004, the Board declared a 3-for-2 stock split and a cash dividend of $0.12 per share (pre-split), payable April 16, 2004. All per-share data in this report has been restated to reflect the split.
• Legal Proceedings (DBCP Lawsuit): A subsidiary, Amvac Chemical Corporation (AMVAC), was named as a defendant in a lawsuit filed in March 2004 (served April 2004) alleging personal injuries (sterility) from exposure to 1,2-dibromo-3-chloropropane (DBCP) on banana plantations in Nicaragua. The case was removed to federal court. The Company intends to vigorously contest the case; no discovery has occurred, and the potential liability is currently unknown.
• Seasonality and Weather: Management notes that quarterly results are subject to significant variation due to weather patterns, crop cycles, and ordering timing. Weather did not have a material adverse effect in Q1 2004.
• Liquidity: The Company maintains a $45 million revolving credit facility (increased from $35 million in March 2004) with $15 million available as of March 31, 2004. Management is exploring financing sources to improve working capital flexibility.

Investor Verification Checklist

• Receivables Quality: Verify the collectability of the $47.1 million in trade receivables, which increased by $19.4 million in one quarter, largely attributed to corn soil insecticide sales with payment terms due in June 2004.
• Inventory Build-up: Assess the necessity and risk of the $4.7 million inventory increase, specifically regarding the new pyrethroid insecticide and other product lines.
• Legal Exposure: Monitor the status of the DBCP litigation (Tellez et al v. Dole Food Company, Inc. et al.) for any updates on discovery or potential settlement ranges.
• Debt Covenants: Review the amended credit agreement terms (maturity May 31, 2005) to ensure compliance with covenants given the increased leverage.
• Stock Split Impact: Confirm that all financial statements and EPS calculations have been correctly restated for the 3-for-2 stock split.